Show simple item record

dc.contributor.authorHesketh-Best, PJ
dc.contributor.authorMouritzen, MV
dc.contributor.authorShandley-Edwards, K
dc.contributor.authorBillington, Richard
dc.contributor.authorUpton, Mathew
dc.date.accessioned2021-02-17T09:09:22Z
dc.date.available2021-02-17T09:09:22Z
dc.date.issued2021-03
dc.identifier.issn2049-632X
dc.identifier.issn2049-632X
dc.identifier.otherftab003
dc.identifier.urihttp://hdl.handle.net/10026.1/16889
dc.description.abstract

<jats:title>ABSTRACT</jats:title> <jats:p>Galleria mellonella is a recognised model to study antimicrobial efficacy; however, standardisation across the scientific field and investigations of methodological components are needed. Here, we investigate the impact of weight on mortality following infection with Methicillin-resistant Staphylococcus aureus (MRSA). Larvae were separated into six weight groups (180–300 mg at 20 mg intervals) and infected with a range of doses of MRSA to determine the 50% lethal dose (LD50), and the ‘lipid weight’ of larvae post-infection was quantified. A model of LD50 values correlated with weight was developed. The LD50 values, as estimated by our model, were further tested in vivo to prove our model.</jats:p> <jats:p>We establish a weight-dependent LD50 in larvae against MRSA and demonstrate that G. mellonella is a stable model within 180–260 mg. We present multiple linear models correlating weight with: LD50, lipid weight, and larval length. We demonstrate that the lipid weight is reduced as a result of MRSA infection, identifying a potentially new measure in which to understand the immune response. Finally, we demonstrate that larval length can be a reasonable proxy for weight. Refining the methodologies in which to handle and design experiments involving G. mellonella, we can improve the reliability of this powerful model.</jats:p>

dc.format.extentftab003-
dc.format.mediumPrint
dc.languageen
dc.language.isoen
dc.publisherOxford University Press (OUP)
dc.subjectMethicillin-resistant Staphylococcus aureus
dc.subjectGalleria mellonella
dc.subjectantibiotic testing
dc.subjectLD50
dc.subjectpre-clinical model
dc.subjectfat body
dc.titleGalleria mellonella larvae exhibit a weight-dependent lethal median dose when infected with methicillin-resistant Staphylococcus aureus
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000637322900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue2
plymouth.volume79
plymouth.publication-statusPublished
plymouth.journalPathogens and Disease
dc.identifier.doi10.1093/femspd/ftab003
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Biomedical Sciences
plymouth.organisational-group/Plymouth/Faculty of Science and Engineering
plymouth.organisational-group/Plymouth/Faculty of Science and Engineering/School of Biological and Marine Sciences
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeUnited States
dcterms.dateAccepted2021-01-11
dc.rights.embargodate2021-12-3
dc.identifier.eissn2049-632X
dc.rights.embargoperiodNot known
rioxxterms.funderInnovate UK
rioxxterms.identifier.projectA new pipeline of first in class antibiotics templated on the bacteriocins
rioxxterms.versionofrecord10.1093/femspd/ftab003
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2021-03
rioxxterms.typeJournal Article/Review
plymouth.funderA new pipeline of first in class antibiotics templated on the bacteriocins::Innovate UK
plymouth.funderA new pipeline of first in class antibiotics templated on the bacteriocins::Innovate UK


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV